Alert
Recommended Alerts
Is International Drug Pricing Suddenly at Our Doorstep? Seven Take-Aways from the Interim Final Rule
On Friday, November 20, the Centers for Medicare & Medicaid Services (CMS) released an interim final rule (IFR) with comment period that implements a nationwide Most Favored Nation (MFN) Medicare fee-for-service (FFS) payment model (MFN Model). The agency says this IFR “will test whether more closely aligning payment for Medicare Part B drugs and biologicals…with international prices and removing incentives to use higher-cost drugs can control unsustainable growth in Medicare Part B spending without adversely affecting quality of care for beneficiaries.” Under the IFR, CMS’s Innovation Center will test the model for seven years, starting in just a matter of weeks – on January 1, 2021.